The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2019

Filed:

Oct. 12, 2017
Applicant:

Global Blood Therapeutics, Inc., South San Francisco, CA (US);

Inventors:

Sean Mark Dalziel, Burlingame, CA (US);

Naveen Bejugam, Santa Clara, CA (US);

Nazila Habibizad, San Mateo, CA (US);

Ali Komeyli, Pacifica, CA (US);

DeMei Leung, Los Altos, CA (US);

Assignee:

Global Blood Therapeutics, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 31/4439 (2006.01); A61K 9/00 (2006.01); A61P 7/00 (2006.01); A61P 35/00 (2006.01); A61P 11/00 (2006.01); A61P 25/28 (2006.01); A61P 7/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2077 (2013.01); A61K 9/0056 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 31/4439 (2013.01); A61P 7/00 (2018.01); A61P 7/06 (2018.01); A61P 11/00 (2018.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01);
Abstract

Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ('Compound 1'), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions.


Find Patent Forward Citations

Loading…